Clinical Movement Dysfunction: An Evidence-Based Overview

Presented by Kyle Kiesel

12-Month Subscription

Unlimited access to:

  • Thousands of CE Courses
  • Patient Education
  • Home Exercise Program
  • And more
Video Runtime: 74 Minutes; Learning Assessment Time: 44 Minutes

Musculoskeletal (MSK) disorders are the number one expense for health insurance companies today, and they are on the rise. Clinically recognizable movement-oriented risk factors have been identified in recent research. Clinicians must understand the contributing factors to suboptimal outcomes and be able to identify MSK risk factors in their patients. In this course, the importance of creating a standardized operating procedure for identifying risk factors is outlined, and learners will recognize that currently there is a lack of standardized clinical movement assessments for individuals in pain. Evidence-based movement screening and testing is discussed, and the Selective Functional Movement Assessment (SFMA) is introduced. This includes the basic classifications of movement patterns, the Top Tier Tests, and scoring criteria for each test. The course will define and apply the concepts of movement diagnosis to help clinicians determine whether a patient has a mobility problem or a motor control problem.

Meet your instructor

Kyle Kiesel

Dr. Kiesel is a professor of physical therapy at the University of Evansville and a cofounder of the Functional Movement System. During his 20 years in academics, he has spent nine years directing programs in athletic training and physical therapy. His areas of research include motor control of the core, breathing, and…

Read full bio

Chapters & learning objectives

Why Global Movement?

1. Why Global Movement?

In this chapter, we cover the research demonstrating that musculoskeletal health disorders are on the rise and that current strategies are not effective. We propose solutions, including the idea of addressing global movement dysfunction in addition to diagnosis-related impairments as one strategy for the management of MSK health.

Clinical Movement Screens/Tests/Assessments: The Evidence

2. Clinical Movement Screens/Tests/Assessments: The Evidence

In this chapter, we cover the risk factors related to MSK health. Many of the strongest risk factors can be easily captured in clinically based movement screens and tests. Understanding this evidence is crucial as we suggest it is the role of rehabilitation providers to manage MSK risk in their patients.

The Clinical Movement Assessment

3. The Clinical Movement Assessment

In this chapter, we cover the background and process of the Selective Functional Movement Assessment (SFMA). This is a tool designed to help the rehabilitation provider identify major movement problems regardless of the patient's medical diagnosis.

Clinical Movement Assessment Demonstration

4. Clinical Movement Assessment Demonstration

In this chapter, Dr. Kiesel takes a patient through the Top Tier patterns of the SFMA. He provides instruction on each of the scoring criteria and clinical tips on how to communicate the testing with patients.

The Movement Diagnosis

5. The Movement Diagnosis

In this chapter, we cover the basis of the movement diagnosis. Most rehabilitation providers are used to treating mobility-oriented movement problems, but some movement problems derive from motor control changes. An accurate diagnosis is crucial for aligning the best treatment strategy for each patient's individual needs.